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Introduction {#sec001}
============

The statement of Hippocrates "Natural forces are the true healers of disease" reflects the fact that thousands of years before any synthetic medicaments were known, nature had been widely considered as the only limitless source of healing components. The ultimate intention has always been to use natural products with favorable antimicrobial, anti-inflammatory and antitumoral properties, without side effects at the chosen concentration, for medicinal purposes. Recently, we have therefore seen diverse plant extracts as well as pure natural compounds as part of various treatment protocols in daily medicinal use \[[@pone.0207574.ref001]--[@pone.0207574.ref005]\]. Especially plant extracts originating from the Mediterranean area belong to the most frequently screened natural resources for application in medicine \[[@pone.0207574.ref006]--[@pone.0207574.ref008]\].

Although almost about 350,000 plant species have been characterized to date, thousands of unexplored plant species need to be studied for their chemical or biological profile and thus, their potential as a non-pharmacological intervention for diverse diseases \[[@pone.0207574.ref009]\]. Following the evolution of all living organisms, plants have nowadays developed their own molecular antimicrobial strategies to survive, by producing secondary metabolites with synergistic action such as small antimicrobial peptides, alkaloids, coumarins, flavonoids, phenols, phenolic acids, quinones, saponins, tannins and terpenoids \[[@pone.0207574.ref010], [@pone.0207574.ref011]\]. For instance, the two main components of *Origanum vulgare*, namely thymol and carvacrol, present synergistic activity against *Streptococcus mutans*, *Streptococcus mitis*, *Prevotella oris*, *Prevotella intermedia*, *Micrococcus luteus* and others \[[@pone.0207574.ref012], [@pone.0207574.ref013]\].

Surprisingly, according to a recent review by Sender *et al*. the ratio between bacterial and host cells in humans is approximately 1:1 \[[@pone.0207574.ref014]\]. In particular, the oral cavity hosts 700 to 1000 different bacterial species mostly situated on both soft and hard tissues, e.g. teeth, gingiva, tongue, cheeks and palate \[[@pone.0207574.ref015]\]. Thus, bacterial diseases in oral cavity are more likely polymicrobial infections which etiologically correlate with caries, pulpitis, gingivitis and periodontitis \[[@pone.0207574.ref016]\]. The complex oral microbial communities are mainly organized in biofilms. During the initial phase of oral biofilm formation, the salivary pellicle is mainly colonized among others by *Streptococcus* spp., which bind with their receptors to host proteins like α-amylase, immunoglobulins, fibronectin, lactoferrin and α~2~-macroglobulin \[[@pone.0207574.ref017], [@pone.0207574.ref018]\]. It was shown that *S*. *mutans* strains in biofilms are up to 70,000 times more acid tolerant than their planktonic counterparts \[[@pone.0207574.ref019]\].

Taking the constantly increasing ineffectiveness of antibiotics into consideration, the necessity to develop new efficient treatment strategies against oral diseases has raised interest in natural products. For instance, nosocomial infections caused by *Acinetobacter baumannii* need an alternative treatment as carbapenem resistances have raised. The plant *Scutellaria baicalensis* seems to have one promising compound named norwogonin which showed antibacterial effects against *A*. *baumannii* \[[@pone.0207574.ref020]\] and *Actinidia deliciosa* methanol extract reduced its production of bacterial biofilm components \[[@pone.0207574.ref021]\]. Because of their secondary metabolism, natural products such as plants yield chemical reactions with significant pharmaceutical effects on various microorganisms. As a result, numerous natural extracts or their main compounds have been screened all over the world, indicating that herbs can improve the oral health \[[@pone.0207574.ref022]\]. Various plant products such as coffee, grape, cranberry juice, tea (green-, cistus-, black tea) have been tested for their potential to treat caries, periodontitis and periimplantitis \[[@pone.0207574.ref023], [@pone.0207574.ref024]\]. Especially Mediterranean herbs seem to have a high efficacy against representative oral microorganisms \[[@pone.0207574.ref024], [@pone.0207574.ref025]\].

Thus, the goal of the present report was to examine the antimicrobial and antibiofilm activity of six Mediterranean natural herb extracts against representative oral microorganisms *in vitro*. More precisely, the methanol extracts of *Cistus creticus* ssp. *creticus*, *Cistus monspeliensis*, *Origanum vulgare*, *Rosmarinus officinalis*, *Salvia sclarea* and *Thymus longicaulis* were tested against eight typical oral pathogenic microorganisms and the fungus *Candida albicans*. Additionally, two reference strains, namely *Staphylococcus aureus* and *Escherichia coli*, residents on skin and intestinal mucosa, respectively, were investigated. The antibiofilm effect of the extracts against *Streptococcus mutans* was also examined. Hence, three antimicrobial assays were applied: the minimal inhibitory concentration (MIC) assay, the minimal bactericidal concentration (MBC) assay and the biofilm plate assay. The null hypothesis was assumed that the tested extracts have no significant antimicrobial and antibiofilm impact on the screened microbial species.

Materials and methods {#sec002}
=====================

Extraction process {#sec003}
------------------

Aerial plant parts of the six different plant species were collected from various places of the Greek periphery. *Cistus creticus* L. (Cistaceae, Lat.: 35^o^ 23′17.76″ N, Long.: 24^o^ 54′50.89″ E, Elevation: 181 m) and *Cistus monspeliensis* L. (Cistaceae, Lat.: 35^o^ 17′29.13″ N, Long.: 25^o^ 32′15.33″ E, Elevation: 63 m) were collected from Crete, *Origanum vulgare* L. (Lamiaceae, Lat.: 37^o^ 16′42.22″ N, Long.: 22^o^ 40′34.36″ E, Elevation: 599 m) from Peloponnese, *Rosmarinus officinalis* L. (Lamiaceae, Lat.: 37^o^ 58′07.98″ N, Long.: 23^o^ 47′11.34″ E, Elevation: 253 m) and *Thymus longicaulis* C. Presl. (Lamiaceae, Lat.: 38^o^ 11′02.26″ N, Long.: 23^o^ 15′19.86″ E, Elevation: 1361 m) from Attiki and *Salvia sclarea* L. (Lamiaceae, Lat.: 39^o^ 52′54.37″ N, Long.: 20^o^ 38′01.89″ E, Elevation: 449 m) from Epirus. The collection sites were on public land. The University of Athens, being a public Institute, reserves the right to collect a small amount of plants for research purposes. No permits or permissions were required to collect samples from these public land areas. A small amount was collected for the needs of the investigation and the plants were not endangered or protected species. A voucher specimen of each plant is deposited at the herbarium of the Department of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens under the following numbers: *C*. *creticus*---KL 057, *C*. *monspeliensis*---KL 060, *O*. *vulgare*---F 009, *R*. *officinalis*---KL 163, *T*. *longicaulis*---P-K 011, *S*. *sclarea*--In 023. Collected plants were grinded (SCIS, Allenwest-Eac ltd) into fine homogeneous powders and extracted with ultrasound assisted the extraction (UAE). An Elma S 100H (Elmasonic) instrument was used with methanol (100%) as extraction solvent for 15 min at room temperature and ratio plant per solvent 1/10 (w/v). Extraction procedure was repeated twice for each sample. Methanol was evaporated to dryness under reduced pressure using a rotary evaporator (Buchi Rotavapor R-200) at 40°C.

High performance thin layer chromatography (HPTLC) analysis {#sec004}
-----------------------------------------------------------

A Camag HPTLC instrumental setup was used for generating the fingerprinting of the various extracts. Extracts' solutions were prepared by dissolving 10 mg of each extract in 1 ml of methanol. The samples of the plant extracts were applied onto 20 × 10 cm TLC plates (silica gel 60, F254, Merck) using the Automatic TLC sampler (ATS4, CAMAG) under the control of the software platform VisionCats 2.3 (Camag) with the following standard settings: 6 tracks with 8 mm bands, 8 mm distance from the lower edge, 20 mm from the left and right edges, and 10.4 mm between the different tracks. The application volume of the samples was 8 μl. The plates were developed with an automatic development chamber (ADC2) using standard settings: 20 min chamber saturation with filter paper, 10 min of plate conditioning at 33% relative humidity (MgCl~2~) and 5 min of plate drying. Dichloromethane, methanol, water (70:30:4; v/v/v) and ethyl acetate, methanol, formic acid, water (50:10:7:1; v/v/v/v) were used as the mobile phases. Images at 254 nm and 366 nm were recorded on a Visualizer 2 Documentation System (CAMAG, Muttenz, Switzerland).

UPLC-HRMS & HRMS/MS analysis {#sec005}
----------------------------

UPLC-HRMS/MS analysis was performed on an AQUITY system (Waters) connected to a LTQ-OrbitrapR XL hybrid mass spectrometer (Thermo Scientific) equipped with an electrospray ionization (ESI) source and operated in negative mode. A UPLC separation gradient was developed in order to efficiently resolve all compounds for a qualitative analysis. The flow rate was set at 0.4 ml min^-1^ and the solvent system was (A) water 0.1% formic acid and (B) acetonitrile. The elution program was: 2% B for 2 min; 100% B in 18 min; and hold for 2 min. After return back to 2% B in 1 min, column equilibration was performed for 4 min at the end of the run. The injection volume was set to 10 μl and samples were injected at 0.3 mg ml^-1^ in water-acetonitrile solution (1:1) on a Supelco Ascentis Express C18 (100 x 2.1 mm i.d, 2.7 μm particle size). The HRMS & HRMS/MS data were acquired in negative mode over 100--1000 m/z range. The MS profile was recorded in full scan mode (scan time = 1 micro scans and maximum inject time = 500 ms). The ESI conditions were as follow: capillary temperature 320°C; capillary voltage -40 V; tube lens -120 V; ESI voltage 2.7 kV. Nitrogen was used as sheath gas (40 Au) and auxiliary gas (8 Au). For the HRMS/MS acquisitions, a data-dependent method including the detection (full scan) and fragmentation of the 3 most intense peaks per scan was used. The mass resolving power was 30,000 for both levels and the normalised collision energy (CID) in the ion trap was set to 35.0% (q = 0.25) for the HRMS/MS experiments. Chromatographic and spectrometric features were used for identification of extracts constituents such as retention time (Rt), polarity, accurate m/z, proposed elemental composition (EC), ring double bond equivalent (RDBeq) values as well as HRMS/MS spectra and derived fragmentation motifs. The raw data were acquired and processed with XCalibur 2.2.4 software from Thermo Scientific.

Bacterial and fungal strains {#sec006}
----------------------------

Ten bacterial strains and one *C*. *albicans* strain were selected. Eight of the tested bacterial strains and *C*. *albicans* are typical residents of the oral cavity. *S*. *aureus* and *E*. *coli*, in contrast, can be mainly detected on skin and within the intestinal flora, respectively, and served as reference species. Among the selected strains, *Streptococcus mutans* DSM (German Collection of Microorganisms and Cell Cultures) 20523, *Streptococcus sobrinus* DSM 20381, *Streptococcus oralis* ATCC 35037, *Enterococcus faecalis* ATCC 29212 *and S*. *aureus* ATCC 25923 are facultative anaerobic Gram-positive species, whereas *E*. *coli* ATCC 25922 is facultative anaerobic but it has a Gram-negative cell wall. *Porphyromonas gingivalis* W381, *Prevotella intermedia* MSP34 (clinical isolate), *Fusobacterium nucleatum* ATCC 25586 and *Parvimonas micra* ATCC 23195 are obligate anaerobic bacteria. The only used fungus *C*. *albicans* DSM 1386 grows both as yeast and filamentous cells. All bacterial and fungal strains were kindly supplied by the Division of Infectious Diseases and the Institute of Medical Microbiology and Hygiene, Faculty of Medicine, University of Freiburg. The microorganisms were deposited at -80°C in basic growth medium containing 15% (v/v) glycerol until their use as formerly described by Jones *et al*. \[[@pone.0207574.ref026]\].

Determination of the minimum inhibitory concentration (MIC) {#sec007}
-----------------------------------------------------------

Firstly, an overnight culture of each bacterial and fungal strain was prepared according to the guidelines of Clinical and Laboratory Standards Institute (CLSI) \[[@pone.0207574.ref027], [@pone.0207574.ref028]\]. Each microorganism was plated on Columbia blood agar plates (CBA) or yeast-cysteine blood agar plates (HCB). Facultative anaerobic bacteria and *C*. *albicans* were incubated on CBA at 37°C and 5--10% CO~2~ atmosphere for 24 h. The anaerobic bacteria were plated on HCB at 37°C for 48 h (anaerobic chamber, Anaerocult, Merck Chemicals GmbH, Darmstadt, Germany). A 0.5 / 1 McFarland standard suspension was prepared in 0.9% saline (NaCl) for facultative anaerobic bacteria and *C*. *albicans*, respectively. For the microdilution assay, all facultative anaerobic strains and *C*. *albicans* were then 1:10 diluted in BBL Mueller Hinton II Broth (Cation-Adjusted) (MHB, BD, Heidelberg, Germany). The anaerobic bacteria were set in Wilkins-Chalgren broth (WCB) as a 0.5 McFarland standard suspension. As previously described (ISO 20776--1: 2006 \[[@pone.0207574.ref029]\]), the cell density of facultative anaerobic bacteria, fungi and obligate anaerobic bacteria should be about 5 x 10^5^, 5 x 10^4^ and 5 x 10^6^ colony forming units (CFU) per ml, respectively. Afterwards, appropriate volumes of the MHB / WCB microbial cultures were transferred into a 96-well microtiter-plate using a multi-channel pipette.

Preparation of extracts and procedure for MIC testing {#sec008}
-----------------------------------------------------

The produced natural plant extracts were dissolved in dimethyl sulfoxide (DMSO, Sigma-Aldrich Chemie GmbH, Steinheim, Germany) at a concentration of 100 mg ml^-1^. All extract solutions in DMSO were screened in a concentration series ranging from 10 mg ml^-1^ to 0.02 mg ml^-1^ at dilution levels starting from 10-fold to 5120-fold. Each well of the 96-well microtiter-plate had a total volume of 100 μl. In order to exclude potential antimicrobial effects of the DMSO residuals, a dilution series of DMSO was examined in parallel. Wells containing solely MHB / WCB and a dilution series of 0.1% chlorhexidine (CHX) served as negative and positive controls for bacterial growth, respectively. Additionally, wells containing MHB / WCB and the added microbial strain acted as growth controls. The possibility of contamination was minimized by using sterile MHB / WCB. Thereafter, *E*. *coli*, *S*. *aureus*, *E*. *faecalis* and *C*. *albicans* were incubated at 37°C for 18 h, the three streptococci strains at 37°C under 5--10% CO~2~ atmosphere for 24 h, while anaerobic bacteria were kept at 37°C for 48 h in anaerobic incubation bags (Anaerocult IS, Merck Chemicals GmbH, Darmstadt, Germany). All assays for each bacterial and fungal strain were performed at least in duplicate. The highest MIC values were taken into consideration in case the MIC values of a specific strain were not identical. If the deviation between the two rows showed more than two dilution levels the determination with this extract was repeated. MIC was defined as the lowest concentration of each natural plant extract at which visible inhibition of bacterial growth was induced. The inhibitory impact of DMSO was taken into consideration if bacterial growth was observed in the co-tested DMSO dilution series.

Determination of the minimum bactericidal concentration (MBC) {#sec009}
-------------------------------------------------------------

The minimum bactericidal concentration (MBC) was also assessed according to the CLSI guidelines \[[@pone.0207574.ref027], [@pone.0207574.ref028]\]. After completion of the MIC assay, the 96-well microtiter-plates were further incubated for MBC testing. In brief, 10 μl from each well containing the tested plant extract concentration series were plated on CBA or HCB. In particular, *E*. *coli*, *S*. *aureus* and *E*. *faecalis* were plated on CBA at 37°C for 24 h, streptococci and *C*. *albicans* were incubated on CBA at 37°C and 5--10% CO~2~ atmosphere for two days. The obligate anaerobes were cultivated on HCB at 37°C for five days. To create anaerobic conditions an anaerobic jar and the Anaerocult. A gas generator system (Merck, Darmstadt, Germany) were used. Finally, the CFU were determined visually. The MBC was defined as the concentration at which a three Log decrease in bacterial growth (= 99.9% inhibition) was detected compared to the growth control.

Biofilm plate assay {#sec010}
-------------------

The biofilm formation test was performed as already described by Al-Ahmad *et al*. \[[@pone.0207574.ref030]\]. Initially, a bacterial strain of *S*. *mutans* R15-8 (clinical isolate) was cultivated overnight at 37°C under aerobic conditions with 5--10% CO~2~ in MHB (BD, Heidelberg, Germany) containing 1% saccharose (MHB-S). Polystyrene 96-well tissue-culture plates (Greiner bio-one, Frickenhausen, Germany) were then filled with 100 μl of MHB-S, including ten different concentrations (0.02--10 mg ml^-1^) of the investigated plant extracts, and 5 μl of the *S*. *mutans* overnight culture (10^8^ CFU ml^-1^) were added to each well. A dilution series of DMSO was examined in parallel. Wells containing solely MHB-S and a dilution series of 0.2% chlorhexidine (CHX) served as negative and positive controls for bacterial growth, respectively. Thereafter, the 96-well plates were incubated for 48 h at 37°C in an aerobic atmosphere with 5--10% CO~2~. The culture medium was then discarded, and the wells were washed three times with 300 ml phosphate-buffered saline (PBS, Life Technologies, Darmstadt, Germany) per plate to remove non-adherent bacteria. The plates were then air dried and stained with Carbol Gentian Violet solution (Carl Roth GmbH + Co. KG, Karlsruhe, Germany) for microscopy, containing 0.1-\<0.25% methyl violet, for 10 min. Excess stain was removed by rinsing the plates with distilled water. Afterwards, the plates were dried for 10 min at 60°C and after dye resolubilization by adding 50 μl of absolute ethanol (99.9% v/v) for analysis (Merck Chemicals GmbH, Darmstadt, Germany) in each well, the optical density was finally measured at 595 nm using the Tecan Infinite 200 plate reader (Tecan, Crailsheim, Germany). All tests were conducted in quadruplicate and the mean values were determined. During the analysis, the antibiofilm effect of each extract on *S*. *mutans* was categorized in three different groups with the aid of two different cut-off values: no biofilm production or C1, moderate biofilm production or C2, and high biofilm production or C3. The low cut-off value was estimated by adding three standard deviations of the blank to the negative control. The high cut-off value resulted after the measurement of the low cut-off value for three times.

Statistical analysis {#sec011}
--------------------

For a descriptive data analysis, the means and standard deviations regarding the optical density (OD) were computed. A two-sample *t* test was used for pairwise group comparisons between the plant extracts and the controls, namely CHX (positive control) and DMSO (negative control). Scatter plots of the OD values reflecting the level of biofilm inhibition by the plant extracts (low, moderate, high) were finally graphically demonstrated. All calculations were done with the statistical software STATA 14.1.

Results {#sec012}
=======

Phytochemical investigation of the plant species {#sec013}
------------------------------------------------

The plants were extracted with methanol using the exhaustive and efficient ultrasound assisted extraction method. For a preliminary phytochemical fingerprinting of the extracts a method was developed with the aid of Camag HPTLC instrumentation. The HPTLC analysis showed that the methanol extracts of the aerial parts of the studied plants contained several bioactive compounds. Two different mobile phases were selected in order to get a better image of the compounds. Visualization of the plates was performed at 254 nm and 366 nm. The chromatograms (Figs [1A--1D](#pone.0207574.g001){ref-type="fig"} and [2A--2D](#pone.0207574.g002){ref-type="fig"}) showed spots, which are characteristic for several Lamiaceae species. In particular, phenolic acids and in particular rosmarinic acid appear as intense fluorescent blue spots in all four plant species (*O*. *vulgare*, *R*. *officinalis*, *T*. *longicaulis* and *S*. *sclarea*), while absorbance at 254 nm is typical of flavonoids. The two other plant species belong to the Cistaceae family (*C*. *creticus* ssp. *creticus* and *C*. *monspeliensis*). As shown in the HPTLC (Figs [1E](#pone.0207574.g001){ref-type="fig"}, [1F](#pone.0207574.g001){ref-type="fig"}, [2E and 2F](#pone.0207574.g002){ref-type="fig"}), evident is the presence of tannins and some phenolic compounds.

![HPTLC chromatograms of (a) *R*. *officinalis*, (b) *S*. *sclarea*, (c) *O*. *vulgare*, (d) *T*. *longicaulis*, (e) *C*. *creticus* and (f) *C*. *monspeliensis* at 254 nm (**A**) and 366 nm (**B**) (mobile phase dichloromethane, methanol, water (70:30:4; v/v/v)).](pone.0207574.g001){#pone.0207574.g001}

![HPTLC chromatograms of (a) *R*. *officinalis*, (b) *S*. *sclarea*, (c) *O*. *vulgare*, (d) *T*. *longicaulis*, (e) *C*. *creticus* and (f) *C*. *monspeliensis* at 254 nm (**A**) and 366 nm (**B**) (mobile phase ethyl acetate, methanol, formic acid, water (50:10:7:1; v/v/v/v)).](pone.0207574.g002){#pone.0207574.g002}

Since the methanol extracts were particularly rich in metabolites of various classes of compounds a more comprehensive characterization of chemical composition of extracts was conducted by LC-HRMS. The methanol extracts were also analyzed by UPLC-ESI-HRMS in order to identify the active compounds of the extracts. Tables [1](#pone.0207574.t001){ref-type="table"}--[6](#pone.0207574.t006){ref-type="table"} summarize all the compounds characterized in the above extracts, including retention times (Rt), elemental composition of the detected ions (EC \[M-H\]-), experimental and theoretical m/z, Delta value (Δm, ppm), rings and double bonds equivalent (RDBeq), MS/MS fragments and identification of putative compounds. Metabolites were assigned by interpreting the mass spectra determined through their MS and MS/MS, taking into account all the data provided by literature \[[@pone.0207574.ref031]--[@pone.0207574.ref042]\]. Thus, a total of 183 compounds, among them a lot in common in all six extracts, belonging to various metabolite classes, were qualitatively characterized. Forty compounds were detected in *R*. *officinalis*, belonging to phenolic acids, flavonoids and triterpenic acids. 7-Methoxyrosmanol, rosmanol isomers and rosmarinic acid were the main metabolites in the methanol extract. Rosmarinic acid was also the major metabolite in the extract of *S*. *sclarea* while various flavonoids were also present. Flavonoids and phenolic acids were identified in the extract of *O*. *vulgare*. Rosmarinic acid was also in this extract the main metabolite along with salvianolic acids. *T*. *longicaulis* was rich in flavonoids and triterpenic acids, while in this extract rosmarinic acid was also the main metabolite. *Cistus* spp. were particularly rich in phenolic compounds and especially flavonoids. Quercetin 3-*O*-β-D-glucopyranoside was the major compound in *C*. *creticus*. In *C*. *monspeliensis* diterpenes were also detected in the methanol extract with cistodioic acid being the major compound. [Fig 3](#pone.0207574.g003){ref-type="fig"} shows the base peak chromatograms (BPCs) of the analyzed extracts.

![LC(ESI-)HRMS chromatograms of the methanol extracts of the tested plants.](pone.0207574.g003){#pone.0207574.g003}
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###### LC(ESI-)HRMS of *R*. *officinalis* methanol extract.

![](pone.0207574.t001){#pone.0207574.t001g}

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  No       Rt\     EC\               Experimental   Theoretical   Δm ppm   RDBeq   Fragments MSMS *(m/z)*         Category of compound\
           (min)   \[M-H\]^-^                                                                                     (*Identification)*
  -------- ------- ----------------- -------------- ------------- -------- ------- ------------------------------ --------------------------------------------------------------
  **1**    0.55    C~7~H~11~O~6~     191.0563       191.05614     1.01     2.5     93, 127                        ***Quinic acid***

  **2**    2.06    C~9~H~9~O~5~      197.0454       197.0455      -0.53    5.5     135, 179                       ***Syringic acid***

  **3**    5.10    C~8~H~7~O~4~      167.0350       167.0350      0.49     5.5     146, 160                       ***Vanilic acid***

  **4**    4.64    C~16~H~17~O~9~    353.0871       353.0878      -1.91    8.5     173, 179                       ***Chlorogenic acid (Isomer 1)***

  **5**    4.90    C~16~H~17~O~9~    353.0871       353.0878      -1.91    8.5     nd                             ***Chlorogenic acid (Isomer 2)***

  **6**    5.06    C~20~H~27~O~12~   459.1501       459.1508      -1.62    7.5     287, 196, 309, 167, 127        ***Paeonolide***

  **7**    5.63    C~12~H~17~O~4~    225.1132       225.1132      0.014    4.5     179                            ***12-Hydroxyjasmonic acid***

  **8**    5.79    C~21~H~19~O~12~   463.0874       463.0882      -1.78    12.5    419                            ***6-Hydroxyluteolin-7-glucoside***

  **9**    6.0     C~24~H~25~O~13~   521.1295       521.1301      -1.16    12.5    359                            ***Rosmarinic acid-3-D-glucoside***

  **10**   6.10    C~27~H~29~O~15~   593.1506       593.1512      -0.94    13.5    473, 353, 503, 196             ***Luteolin-7-O-rutinoside***

  **11**   6.37    C~22~H~21~O~12~   477.1036       477.1038      -0.50    12.5    315, 197, 179,135              ***Nepitrin***

  **12**   6.65    C~22~H~19~O~10~   431.0977       431.09784     -1.44    12.5    269                            ***Apigenin-7-O-glucoside***

  **13**   6.71    C~28~H~33~O~15~   609.1821       609.1825      -0.69    12.5    461                            ***Hesperidin***

  **14**   6.78    C~18~H~15~O~8~    359.0772       359.0772      -0.1     11.5    161, 179, 197, 135             ***Rosmarinic acid***

  **15**   6.92    C~21~H~17~O~12~   461.0724       461.0725      -0.21    13.5    285                            ***Luteolin-3-glucuronide***

  **16**   7.18    C~27~H~33~O~12~   549.1973       549.1977      -0.77    11.5    218, 475, 359                  ***Eucommin A***

  **17**   7.23    C~29~H~25~O~14~   597.1244       597.1250      -0.98    17.5    555                            ***Pterogynoside***

  **18**   7.43    C~32~H~29~O~15~   653.1501       653.1512      -1.60    18.5    503, 593, 331                  ***Feruloylnepitrin***

  **19**   7.47    C~23~H~19~O~13~   503.0829       503.0831      -0.39    14.5    285, 399                       ***Luteolin-3′-O-(2″-O-acetyl)-β-D glucuronide (Isomer 1)***

  **20**   7.61    C~15~H~9~O~6~     285.0402       285.0405      -0.94    11.5    146, 190, 262                  ***Luteolin***

  **21**   7.73    C~23~H~19~O~13~   503.0827       503.0831      -0.75    14.5    285, 399                       ***Luteolin-3′-O-(2″-O-acetyl)-β-D glucuronide (Isomer 2)***

  **22**   7.97    C~9~H~7~O~4~      179.0352       179.0350      1.14     6.5     135, 160                       ***Caffeic acid***

  **23**   8.29    C~15~H~9~O~5~     269.0452       269.0455      -1.30    11.5    nd                             ***Apigenin***

  **24**   8.43    C~16~H~11~O~6~    299.0558       299.05561     -0.98    11.5    179                            ***Diosmetin***

  **25**   9.40    C~17~H~13~O~6~    313.0716       313.0718      -0.63    11.5    nd                             ***Cirsimaritin***

  **26**   9.43    C~20~H~25~O~5~    345.1708       345.1707      0.08     8.5     301, 283                       ***Rosmanol (Isomer 1)***

  **27**   9.79    C~20~H~25~O~5~    345.1706       345.1707      -0.35    8.5     283                            ***Rosmanol (Isomer 2)***

  **28**   10.16   C~20~H~25~O~5~    345.1708       345.1707      0.08     8.5     nd                             ***Rosmanol (Isomer 3)***

  **29**   11.79   C~19~H~23~O~3~    299.1651       299.1653      -0.66    8.5     284                            ***Miltipolone***

  **30**   11.95   C~21~H~27~O~5~    359.1863       359.1864      -0.24    8.5     315, 287, 196, 272, 167        ***7-Methoxyrosmanol***

  **31**   12.52   C~20~H~23~O~5~    343.1549       343.1551      -0.46    9.5     325, 300, 287, 196, 315        ***Rosmadial***

  **32**   12.82   C~20~H~27~O~4~    331.1912       331.1915      -0.87    7.5     nd                             ***Carnosic acid***

  **33**   12.84   C~20~H~27~O~3~    315.1963       315.1966      -0.78    7.5     287, 196, 167                  ***Rosmaridiphenol***

  **34**   12.94   C~30~H~47~O~4~    471.3477       471.3480      -0.49    7.5     287, 196, 453, 287, 196, 167   ***Anemosapogenin***

  **35**   13.50   C~30~H~47~O~4~    471.3476       471.3480      -0.82    7.5     194, 116, 329                  ***Augustic acid***

  **36**   14.01   C~21~H~29~O~4~    345.2068       345.2071      -0,91    7.5     301, 286                       ***Methyl carnosate***

  **37**   15.28   C~30~H~47~O~3~    455.3527       455.3531      -0.82    7.5     452                            ***Betulinic acid***

  **38**   15.32   C~30~H~47~O~3~    455.3524       455.3531      -1.43    7.5     407                            ***Oleanolic acid***

  **39**   15.34   C~30~H~47~O~3~    455.3528       455.3531      -0.62    7.5     453                            ***Ursolic acid***

  **40**   16.27   C~30~H~45~O~3~    453.3369       453.3374      -1.11    8.5     nd                             ***Micromeric acid***

  **41**   18.23   C~30~H~47~O~4~    471.3474       471.3480      -0.49    8.5     467                            ***Benthamic acid***
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

10.1371/journal.pone.0207574.t002

###### LC(ESI-)HRMS of *S*. *sclarea* methanol extract.

![](pone.0207574.t002){#pone.0207574.t002g}

  --------------------------------------------------------------------------------------------------------------------------------------------------------
  No       Rt\     EC\               Experimental   Theoretical   Δm ppm   RDBeq   Fragments MSMS\           Category of compound\
           (min)   \[M-H\]^-^                                                      (m/z)                     (*Identification)*
  -------- ------- ----------------- -------------- ------------- -------- ------- ------------------------- ---------------------------------------------
  **1**    2.18    C~9~H~9~O~5~      197.0454       197.0455      -0.69    5.5     179, 153, 72              ***Salvianic acid A***

  **2**    4.86    C~9~H~7~O~4~      179.0350       179.0350      0.37     6.5     nd                        ***Caffeic acid***

  **3**    5.34    C~27~H~29~O~15~   593.1501       593.1512      -1.76    13.5    287, 196, 323, 269, 194   ***luteolin-7-O-rutinoside***

  **4**    5.36    C~16~H~17~O~9~    353.0872       353.0878      -1.57    8.5     173, 179                  ***Chlorogenic acid***

  **5**    5.78    C~15~H~9~O~7~     301.0349       301.0354      -1.43    11.5    nd                        ***Quercetin***

  **6**    5.79    C~21~H~17~O~13~   477.0670       477.0675      -1.00    13.5    161, 301, 315, 359        ***Quercetin-3-glucuronide (Miquelianin)***

  **7**    5.80    C~21~H~17~O~13~   477.06670      477.06675     -1.00    13.5    315, 300, 287, 196        ***6-hydroxyluteolin 7-O-glucuronide***

  **8**    5.86    C~27~H~29~O~16~   609.1465       609.1461      0.71     13.5    301                       ***Rutin***

  **9**    6.02    C~14~H~5~O~8~     300.9986       300.9990      -1.30    12.5    nd                        ***Ellagic acid***

  **10**   6.16    C~21~H~20~O~12~   463.0876       463.0876      -1.32    12.5    419                       ***Hyperoside***

  **11**   6.35    C~24~H~25~O~13~   521.1296       521.1301      -0.93    12.5    359                       ***Rosmarinic acid-3-D-glucoside***

  **12**   6.66    C~7~H~6~O~3~      137.0248       137.0244      2.76     5.5     108, 93                   ***Hydroxybenzoic acid***

  **13**   6.67    C~21~H~19~O~10~   431.0980       431.0984      -0.87    12.5    269                       ***Apigenin 7-O-D-glucoside***

  **14**   6.72    C~21~H~17~O~11~   445.0775       445.0776      -0.40    13.5    287, 161, 196, 194, 115   ***Apigenin-7-O-β-D glucuronide***

  **15**   6.79    C~18~H~15~O~8~    359.0770       359.0772      -0.68    11.5    161, 179, 197             ***Rosmarinic acid***

  **16**   6.92    C~21~H~17~O~12~   461.0725       461.0725      -0.08    13.5    285                       ***Luteolin-7-O-β-D glucuronide***

  **17**   7.11    C~27~H~21~O~12~   537.1035       537.1038      -0.62    17.5    135, 185, 25, 313, 461    ***Salvianolic acid I***

  **18**   7.18    C~27~H~21~O~12~   473.10855      473.10855     -0.81    13.5    287, 429, 196, 167        ***Apigenin-acetylglucoside***

  **19**   7.60    C~15~H~9~O~6~     285.0403       285.0405      -0.41    11.5    133, 151, 197, 213        ***Luteolin***

  **20**   7.76    C~16~H~11~O~7~    315.05063      315.05063     -1.26    11.5    83, 145, 187              ***Rhamnetin***

  **21**   7.80    C~16~H~11~O~6~    299.0558       299.0561      -1.08    11.5    285                       ***Diosmetin***

  **22**   7.99    C~19~H~17~O~8~    373.0925       373.0929      -1.05    11.5    135, 175, 179, 197        ***Methyl rosmarinate***

  **23**   8.16    C~36~H~29~O~16~   717.1448       717.1461      -1.85    22.5    519                       ***Salvianolic acid B***

  **24**   8.28    C~15~H~9~O~5~     269.0453       269.0455      -0.73    11.5    117, 151                  ***Apigenin***

  **25**   9.32    C~16~H~11~O~6~    299.0557       299.0561      -1.39    11.5    299                       ***Hispidulin***

  **26**   9.40    C~17~H~13~O~6~    313.0714       313.0718      -1.21    11.5    298, 196                  ***Cirsimaritin***

  **27**   9.45    C~20~H~25~O~5~    345.1702       345.1707      -1.50    8.5     345                       ***Epi-rosmanol***

  **28**   10.19   C~16~H~11~O~5~    283.0610       283.0612      -0.78    11.5    283                       ***Genkwanin***
  --------------------------------------------------------------------------------------------------------------------------------------------------------

10.1371/journal.pone.0207574.t003

###### LC(ESI-)HRMS of *O*. *vulgare* methanol extract.

![](pone.0207574.t003){#pone.0207574.t003g}

  ----------------------------------------------------------------------------------------------------------------------------------------------------
  No       Rt\     EC\               Experimental   Theoretical   Δm ppm   RDBeq   Fragments MSMS\                Category of compound\
           (min)   \[M-H\]^-^                                                      (m/z)                          (*Identification)*
  -------- ------- ----------------- -------------- ------------- -------- ------- ------------------------------ ------------------------------------
  **1**    0.57    C~7~H~11~O~6~     191.0563       191.0561      1.01     2.5     127, 173, 71, 85               ***Quinic acid***

  **2**    2.09    C~9~H~9~O~5~      197.0454       197.0455      -0.69    5.5     179                            ***Salvianic acid A***

  **3**    2.23    C~7~H~5~O~4~      153.0196       153.0193      1.50     5.5     nd                             ***Dihydroxybenzoic acid***

  **4**    4.49    C~13~H~15~O~8~    299.0768       299.0772      -1.63    6.5     nd                             ***Hydroxybenzoic acid hexose***

  **5**    4.86    C~9~H~7~O~4~      179.0350       179.0350      0.37     6.5     135, 167, 71                   ***Caffeic acid***

  **6**    4.91    C~16~H~17~O~9~    353.0872       353.0878      -1.57    8.5     173, 179                       ***Chlorogenic acid***

  **7**    5.08    C~8~H~7~O~4~      167.0352       167.0350      1.22     5.5     nd                             ***Vanilic acid***

  **8**    5.11    C~27~H~29~O~16~   609.1453       609.1461      -1.38    13.5    489, 287, 196, 519, 167        ***Luteolin-6*,*8-C-dihexose***

  **9**    5.34    C~27~H~29~O~15~   593.1506       593.1512      -0.94    13.5    473, 353, 503, 196             ***Apigenin-6*,*8-di-C-hexoside***

  **10**   5.66    C~21~H~19~O~11~   447.0930       447.0933      -0.52    12.5    327, 353, 429, 287, 196        ***Isoorientin***

  **11**   5.67    C~9~H~7~O~3~      163.04033      163.04033     1.60     6.5     nd                             ***p-Coumaric acid***

  **12**   6.08    C~21~H~19~O~10~   431.0978       431.0984      -1.30    12.5    341, 311, 287, 196             ***Vitexin/Isovitexin***

  **13**   6.14    C~15~H~11~O~7~    303.0508       303.0510      -0.60    10.5    287, 196, 96, 71               ***Taxifolin***

  **14**   6.21    C~11~H~9~O~7~     253.0352       253.0354      -0.80    7.5     nd                             ***Chrysin***

  **15**   6.26    C~21~H~17~O~12~   461.0722       461.0725      -0.68    13.5    285                            ***Kaempferol-O glucuronide***

  **16**   6.31    C~16~H~13~O~6~    301.0717       301.0718      -0.25    10.5    nd                             ***Hesperetin***

  **17**   6.47    C~27~H~21~O~12~   537.1038       537.1038      -0.05    17.5    493                            ***Salvianolic acid I***

  **18**   6.62    C~27~H~21~O~12~   537.1037       537.1038      -0.28    17.5    519                            ***Salvianolic acid H***

  **19**   6.73    C~21~H~17~O~11~   445.0774       445.0776      -0.47    13.5    269, 287, 196, 302, 162, 124   ***Apigenin 7-O glucuronide***

  **20**   6.77    C~18~H~15~O~8~    359.0772       359.0772      -0.08    11.5    197, 161                       ***Rosmarinic acid***

  **21**   6.89    C~27~H~21~O~12~   537.1038       537.1038      -0.05    17.5    493                            ***Lithospermic acid***

  **22**   7.19    C~36~H~29~O~16~   717.1456       717.14561     -0.66    22.5    519, 475                       ***Salvianolic acid E/B***

  **23**   7.38    C~26~H~19~O~10~   491.0981       491.0981      -0.58    17.5    311, 135                       ***Salvianolic acid C***

  **24**   7.48    C~15~H~11~O~6~    287.0560       287.0561      -0.49    10.5    151, 135, 107                  ***Eriodictyol***

  **25**   7.61    C~15~H~9~O~6~     285.0403       285.0405      -0.41    11.5    nd                             ***Kaempferol***

  **26**   7.63    C~15~H~9~O~6~     285.0403       285.0405      -0.41    11.5    nd                             ***Luteolin***

  **27**   7.94    C~28~H~31~O~15~   607.1664       607.1668      -0.65    13.5    299                            ***Diosmin***

  **28**   8.04    C~17~H~13~O~7~    329.0663       329.0667      -1.00    11.5    314, 299                       ***Quercetin dimethyl ether***

  **29**   8.28    C~15~H~9~O~5~     269.0455       269.0455      -0.16    11.5    nd                             ***Apigenin***

  **30**   9.02    C~16~H~13~O~6~    301.2018       301.2020      -0.67    2.5     165, 135, 299                  ***Dihydro-kaempferide***
  ----------------------------------------------------------------------------------------------------------------------------------------------------

10.1371/journal.pone.0207574.t004

###### LC(ESI-)HRMS of *T*. *longicaulis* methanol extract.

![](pone.0207574.t004){#pone.0207574.t004g}

  ---------------------------------------------------------------------------------------------------------------------------------------------------
  No       Rt\     EC\               Experimental   Theoretical   Δm ppm   RDBeq   Fragments MSMS\           Category of compound\
           (min)   \[M-H\]^-^                                                      (m/z)                     *(Identification)*
  -------- ------- ----------------- -------------- ------------- -------- ------- ------------------------- ----------------------------------------
  **1**    2.08    C~9~H~9~O~5~      197.04544      197.04544     -0.53    5.5     179                       ***3*,*4 Dihydroxyphenylacetic acid***

  **2**    2.19    C~7~H~5~O~4~      153.0195       153.0193      1.20     5.5     109, 71                   ***Protocatechuic acid***

  **3**    4.75    C~16~H~17~O~9~    353.0872       353.0878      -1.74    8.5     173, 179                  ***Chlorogenic acid***

  **4**    4.86    C~9~H~7~O~4~      179.0350       179.0350      0.29     6.5     135, 71, 167              ***Caffeic acid (Isomer I)***

  **5**    5.13    C~9~H~7~O~4~      179.0350       179.0350      0.34     6.5     135, 71, 167              ***Caffeic acid (Isomer II)***

  **6**    5.33    C~27~H~29~O~15~   593.1506       593.1512      -0.94    13.5    473, 353, 196, 287, 503   ***Apigenin diglucoside***

  **7**    5.68    C~21~H~19~O~11~   447.09308      447.09308     -0.46    12.5    285                       ***Luteolin O-Hexoside***

  **8**    5.75    C~12~H~19~O~12~   463.0879       463.0882      -0.60    12.5    301                       ***Quercetin-O-hexoside***

  **9**    5.77    C~21~H~19~O~12~   463.0881       463.0882      -0.27    12.5    301, 151                  ***Quercetin 3-O-glucoside***

  **10**   6.0     C~27~H~29~O~16~   609.1465       609.1461      0.71     13.5    301                       ***Rutin***

  **11**   6.12    C~21~H~21~O~11~   449.1087       449.1089      -0.58    11.5    287, 196, 313             ***Eriodictyol O-hexoside***

  **12**   6.13    C~30~H~25~O~13~   593.1291       593.1303      -1.64    18.5    285, 196, 167, 478        ***Kaempferol diglucoside***

  **13**   6.20    C~21~H~19~O~11~   447.09308      447.09308     -0.46    12.5    285                       ***Luteolin 7-glucoside***

  **14**   6.28    C~24~H~25~O~13~   521.1299       521.1301      -0.23    12.5    359, 287, 196             ***Rosmarinic acid-3-D-glucoside***

  **15**   6.81    C~18~H~15~O~8~    359.0769       359.0772      -0.85    11.5    161, 197, 179, 135        ***Rosmarinic acid***

  **16**   7.65    C~27~H~21~O~12~   537.1036       537.1038      -0.39    17.5    493                       ***Lithospermic acid A***

  **17**   7.96    C~19~H~17~O~8~    373.0926       373.0929      -1.05    11.5    179                       ***Methyl rosmarinate***

  **18**   8.28    C~15~H~9~O~5~     269.0454       269.0455      -0.50    11.5    nd                        ***Apigenin***

  **19**   11.67   C~30~H~47~O~4~    471.3477       471.3480      -0.49    7.5     287                       ***Anemosapogenin***

  **20**   12.07   C~30~H~47~O~4~    471.3476       471.3480      -0.82    7.5     287                       ***Augustic acid***

  **21**   12.91   C~30~H~47~O~4~    471.3474       471.3480      -0.49    7.5     287                       ***Benthamic acid***

  **22**   15.28   C~30~H~47~O~3~    455.3526       455.3531      -1.05    7.5     287                       ***Betulinic acid***

  **23**   15.63   C~30~H~47~O~3~    455.3528       455.3531      -0.49    7.5     287                       ***Oleanolic acid***

  **24**   15.65   C~30~H~47~O~3~    455.3530       455.3531      -0.15    7.5     287                       ***Ursolic acid***

  **25**   16.29   C~30~H~45~O~3~    453.3369       453.3374      -1.11    8.5     287, 196                  ***Micromeric acid***
  ---------------------------------------------------------------------------------------------------------------------------------------------------

10.1371/journal.pone.0207574.t005

###### LC(ESI-)HRMS of *C*. *creticus* methanol extract.

![](pone.0207574.t005){#pone.0207574.t005g}

  -------------------------------------------------------------------------------------------------------------------------------------------------
  No       Rt\     EC\               Experimental   Theoretical   Δm ppm   RDBeq   Fragments MSMS\      Category of compound\
           (min)   \[M-H\]^-^                                                      (m/z)                (*Identification)*
  -------- ------- ----------------- -------------- ------------- -------- ------- -------------------- -------------------------------------------
  **1**    0.55    C~7~H~11~O~6~     191.0563       191.0561      1.01     2.5     173, 127, 85         ***Quinic acid***

  **2**    0.70    C~7~H~9~O~5~      173.0456       173.0455      0.18     3.5     nd                   ***Shikimic acid***

  **3**    0.93    C~13~H~15~O~10~   331.0666       331.0671      -1.45    5.5     nd                   ***Glucogallin***

  **4**    1.08    C~7~H~5~O~5~      169.0143       169.0142      0.57     5.5     125                  ***Gallic acid***

  **5**    2.29    C~13~H~15~O~9~    315.0716       315.0722      -1.87    6.5     153, 287, 196        ***Gentisoil glucoside***

  **6**    2.38    C~15~H~13~O~7~    305.0661       305.0667      -1.78    9.5     179, 219, 165, 261   ***Epigallocatechin***

  **7**    4.04    C~12~H~13~O~8~    285.0613       285.0616      -1.09    6.5     153, 109             ***Uralenneoside***

  **8**    4.21    C~34~H~23~O~22~   783.0701       783.0686      1.81     23.5    nd                   ***Pedunculagin***

  **9**    4.65    C~15~H~13~O~6~    289.07135      289.07135     -1.42    9.5     nd                   ***Cathechin***

  **10**   4.67    C~20~H~19~O~14~   483.0714       483.0718      -1.52    9.5     nd                   ***Digaloil-β-D-glucopiranose***

  **11**   4.80    C~27~H~21~O~18~   633.07220      633.07220     -1.78    17.5    300, 287, 196, 478   ***Strictinin***

  **12**   4.94    C~21~H~21~O~13~   481.0983       481.0988      -0.90    11.5    287, 196, 245        ***Mirciaphenone B***

  **13**   5.33    C~27~H~29~O~15~   593.1506       593.1512      -0.94    13.5    473                  ***Apigenin diglucoside***

  **14**   5.64    C~27~H~29~O~17~   625.1401       625.1410      -1.51    13.5    463, 301             ***Quercetin diglucoside***

  **15**   5.65    C~21~H~19~O~13~   479.08261      479.08261     -1.04    12.5    nd                   ***Myricetin-3-O-glucoside***

  **16**   5.82    C~19~H~13~O~12~   433.0406       433.04012     -1.38    13.5    301                  ***Ellagic acid-7-xyloside***

  **17**   6.01    C~27~H~29~O~16~   609.1450       609.1461      -1.78    13.5    287, 301, 196, 478   ***Kaempferol diglucoside***

  **18**   6.06    C~27~H~29~O~16~   609.1446       609.1461      -2.48    13.5    301                  ***Rutin***

  **19**   6.02    C~21~H~19~O~12~   463.0881       463.0882      -0.27    12.5    301, 151             ***Quercetin 3-O-β-D-glucopyranoside***

  **20**   6.15    C~21~H~19~O~12~   463.0877       463.0882      -1.06    12.5    316                  ***Myricetin-3-O-rhamnoside***

  **21**   6.34    C~14~H~5~O~8~     300.9988       300.9990      -0.59    12.5    nd                   ***Ellagic acid***

  **22**   6.37    C~27~H~29~O~15~   593.1506       593.1512      -0.94    13.5    287                  ***Luteolin-7-O-rutinoside***

  **23**   6.56    C~21~H~19~O~11~   447.0930       447.0933      -0.73    12.5    301                  ***Isoorientin***

  **24**   7.0     C~30~H~25~O~16~   625.1188       625.1199      -1.78    18.5    316, 479             ***Myricetin-O-rhamnoside-O-hexoside***

  **25**   7.65    C~30~H~25~O~13~   593.1294       593.1301      -1.28    18.5    285, 447             ***Kaempferol -O-rhamnoside-O-hexoside***

  **26**   7.81    C~30~H~25~O~13~   593.1291       593.1303      -1.64    18.5    285, 447             ***Kaempferol diglucoside***

  **27**   8.27    C~15~H~9~O~5~     269.0454       269.0455      -0.39    11.5    nd                   ***Apigenin***

  **28**   8.72    C~16~H~11~O~6~    299.05585      299.05585     -0.88    11.5    284, 196             ***Kaempferol methylether***

  **29**   10.08   C~16~H~11~O~5~    283.0611       283.0612      -0.35    11.5    268                  ***Apigenin methylether***

  **30**   10.09   C~16~H~11~O~5~    283.0608       283.0612      -1.32    11.5    283                  ***Apigenin methylether***
  -------------------------------------------------------------------------------------------------------------------------------------------------

10.1371/journal.pone.0207574.t006

###### LC(ESI-)HRMS of *C*. *monspeliensis* methanol extract.

![](pone.0207574.t006){#pone.0207574.t006g}

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  No       Rt\     EC\               Experimental   Theoretical   Δm ppm   RDBeq   Fragments MSMS\           Category of compound\
           (min)   \[M-H\]^-^                                                      (m/z)                     (*Identification)*
  -------- ------- ----------------- -------------- ------------- -------- ------- ------------------------- -------------------------------------------------------------------
  **1**    0.56    C~7~H~11~O~6~     191.0562       191.0561      0.61     2.5     173, 127, 85              ***Quinic acid***

  **2**    0.69    C~7~H~9~O~5~      173.0456       173.0455      0.18     3.5     nd                        ***Shikimic acid***

  **3**    1.15    C~13~H~15~O~10~   331.0667       331.0671      0.57     5.5     nd                        ***Glucogallin***

  **4**    1.08    C~7~H~5~O~5~      169.0143       169.0142      0.57     5.5     125                       ***Gallic acid***

  **5**    2.19    C~7~H~5~O~4~      153.0195       153.0193      1.50     5.5     109, 71                   ***Dihydroxybenzoic acid***

  **6**    2.29    C~13~H~15~O~9~    315.0716       315.0722      -1.87    6.5     153, 287, 196             ***Gentisoil glucoside***

  **7**    4.06    C~12~H~13~O~8~    285.0611       285.0616      -1.84    6.5     153, 109                  ***Uralenneoside***

  **8**    4.40    C~8~H~7~O~5~      183.0299       183.0299      -0.05    5.5     nd                        ***Methyl gallate***

  **9**    4.64    C~27~H~29~O~17~   625.1401       625.1410      -1.51    13.5    463, 301                  ***Quercetin diglucoside***

  **10**   5.35    C~27~H~29~O~15~   593.1506       593.1512      -0.94    13.5    287                       ***Luteolin-7-O-rutinoside***

  **11**   5.65    C~21~H~19~O~13~   479.08261      479.08261     -1.04    12.5    316, 287, 196             ***Myricetin-3-O-glucoside***

  **12**   5.80    C~19~H~13~O~12~   433.0406       433.04012     -1.45    13.5    301                       ***Ellagic acid-7-xyloside***

  **13**   5.95    C~20~H~17~O~12~   449.0721       449.0725      -0.97    12.5    317, 287, 196             ***Myricetin 3\'-xyloside***

  **14**   6.00    C~14~H~5~O~8~     300.9988       300.9990      -0.59    12.5    nd                        ***Ellagic acid***

  **15**   6.08    C~21~H~19~O~12~   463.0881       463.0882      -0.27    12.5    301, 151                  ***Quercetin 3-O-β-D-glucopyranoside***

  **16**   6.15    C~21~H~19~O~12~   463.0877       463.0882      -1.06    12.5    316                       ***Myricetin-3-O-rhamnoside***

  **17**   6.34    C~20~H~17~O~11~   433.0775       433.0776      -0.41    12.5    301, 287, 196, 167, 126   ***Quercetin 3-alpha-L-arabinofuranoside (Avicularin Isomer 1)***

  **18**   6.47    C~20~H~17~O~11~   433.0775       433.0776      -0.41    12.5    301, 287, 196, 167, 126   ***Quercetin 3-alpha-L-arabinofuranoside (Avicularin Isomer 2)***

  **19**   6.55    C~21~H~19~O~11~   447.0928       447.0933      -1.00    12.5    301                       ***Isoorientin***

  **20**   6.74    C~8~H~7~O~5~      293.1390       293.1394      -1.49    6.5     249, 274, 287, 205, 196   ***Propanoic acid methyl ester***

  **21**   6.95    C~30~H~25~O~16~   625.1188       625.1199      -1.78    18.5    316, 479                  ***Myricetin-O-rhamnoside-O-hexoside***

  **22**   7.61    C~30~H~25~O~13~   593.1294       593.1301      -1.28    18.5    285, 447                  ***Kaempferol-O-rhamnoside-O-hexoside***

  **23**   7.69    C~15~H~9~O~7~     301.0349       301.0354      -1.43    11.5    178, 151, 196, 287, 71    ***Quercetin***

  **24**   7.79    C~30~H~25~O~13~   593.1291       593.1303      -1.64    18.5    285, 447                  ***Kaempferol diglucoside***

  **25**   8.04    C~17~H~13~O~7~    329.0663       329.0667      -1.00    11.5    314, 287, 196, 167        ***Quercetin dimethyl ether***

  **26**   9.14    C~18~H~15~O~8~    359.0772       359.0772      -0.08    11.5    344, 329                  ***Rosmarinic acid***

  **27**   9.39    C~20~H~29~O~5~    349.2019       349.2020      -0.32    6.5     305                       ***Andrographolide***

  **28**   9.66    C~20~H~31~O~4~    335.2228       335.2228      0.16     5.5     291, 287, 196, 126, 100   ***Cistodioic acid***

  **29**   10.95   C~19~H~17~O~8~    373.0923       373.0929      -1.70    11.5    358, 287, 196             ***Eriostemin***

  **30**   12.0    C~22~H~33~O~5~    377.2330       377.2333      -0.91    6.5     nd                        ***Laurifolic acid***
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*C*. *creticus* and *C*. *monspeliensis* exhibited high antibacterial and antibiofilm activity against obligate anaerobes and *S*. *mutans*, respectively {#sec014}
---------------------------------------------------------------------------------------------------------------------------------------------------------

The mean MIC / MBC values for the methanol extract of *C*. *creticus* are shown in [Table 7](#pone.0207574.t007){ref-type="table"}. Under its influence, especially the growth of the obligate anaerobes was efficiently reduced at low inhibitory concentrations ranging from 0.08 mg ml^-1^ (*P*. *gingivalis*, *P*. *micra*) to 0.60 mg ml^-1^ (*F*. *nucleatum*), while MBC values varied from 0.15 mg ml^-1^ (*P*. *gingivalis*, *P*. *micra*) to 0.60 mg ml^-1^ (*P*. *intermedia*, *F*. *nucleatum*). Likewise, *S*. *oralis* was eliminated at a bactericidal *C*. *creticus* concentration of 0.60 mg ml^-1^. Additionally, the extract was very effective against *S*. *aureus* (MIC = 0.60 mg ml^-1^), whereas it had a moderate effect on *S*. *sobrinus* and *E*. *faecalis* with a MIC value of 5.00 mg ml^-1^. No significant antimicrobial effect was observed on *S*. *mutans*, *C*. *albicans* and *E*. *coli*. The biofilm plate assay revealed a moderate reduction of biofilm production as shown in [Fig 4](#pone.0207574.g004){ref-type="fig"}. The biofilm formation of *S*. *mutans* was significantly inhibited (mean OD~595~ = 0.231) at a *C*. *creticus* concentration of 0.60 mg ml^-1^ (low cut-off value OD~595~ = 0.143), while high *S*. *mutans* biofilm formation was observed at 0.15 mg ml^-1^ (high cut-off value OD~595~ = 0.428).

![Diagrams depicting the antibiofilm effect of six Mediterranean herb extracts against *S*. *mutans*.\
The low and high cut-off OD~595~ values were estimated at 0.143 and 0.428, respectively. High *S*. *mutans* biofilm inhibition is exhibited at OD~595~ values ≤0.143, whereas *S*. *mutans* moderate biofilm formation is displayed at 0.143 ≤ OD~595~ values ≤0.428. DMSO and CHX concentrations are shown for each extract concentration. Hash symbols and asterisks represent statistically significant differences (p \< 0.01 and p \< 0.05), respectively.](pone.0207574.g004){#pone.0207574.g004}

10.1371/journal.pone.0207574.t007

###### Antimicrobial activity in mg ml^-1^ of *C*. *creticus* methanol extract.

![](pone.0207574.t007){#pone.0207574.t007g}

  *C*. *creticus*                                                
  -------------------------------------- ------- ------- ------- -------
  *Streptococcus mutans* DSM 20523       5.00    10.00   5.00    NA
  *Streptococcus sobrinus* DSM 20381     5.00    10.00   20.00   20.00
  *Streptococcus oralis* ATCC 35037      0.30    0.60    10.00   20.00
  *Enterococcus faecalis* ATCC 29212     5.00    10.00   20.00   NA
  *Candida albicans* DSM 1386            10.00   10.00   10.00   20.00
  *Escherichia coli* ATCC 25922          NA      NA      20.00   NA
  *Staphylococcus aureus* ATCC 25923     0.60    2.50    20.00   NA
  *Porphyromonas gingivalis* W381        0.08    0.15    20.00   20.00
  *Prevotella intermedia* MSP 34         0.30    0.60    5.00    5.00
  *Fusobacterium nucleatum* ATCC 25586   0.60    0.60    10.00   10.00
  *Parvimonas micra* ATCC 23195          0.08    0.15    10.00   20.00

NA: No activity observed, MIC or MBC of extracts and DMSO at 10.00 mg ml^-1^ and 20%, respectively.

MIC = extract concentration at which the OD measurement revealed minimal bacterial growth.

MBC = extract concentration at which a 3-Log reduction (99.9%) of the bacterial growth was induced.

[Table 8](#pone.0207574.t008){ref-type="table"} summarizes the MIC and MBC values for the methanol extract of *C*. *monspeliensis*. In general, *C*. *monspeliensis* exhibited significant bactericidal effects against the obligate anaerobes with a MIC range from 0.04 mg ml^-1^ (*P*. *gingivalis*, *P*. *micra*) to 0.60 mg ml^-1^ (*F*. *nucleatum*), while the extract had no antimicrobial impact on *E*. *coli* and *C*. *albicans*. A moderate inhibitory effect was observed for *S*. *mutans* (MIC = 2.50 mg ml^-1^). The MIC and MBC values were estimated at 0.15 mg ml^-1^ and 0.60 mg ml^-1^ for *S*. *oralis*, whereas *E*. *faecalis* was less susceptible to *C*. *monspeliensis* (MIC = 5.00 mg ml^-1^; MBC = 10.00 mg ml^-1^). The methanol extract of *C*. *monspeliensis* had a high inhibitory effect on *S*. *mutans* biofilm formation ([Fig 4](#pone.0207574.g004){ref-type="fig"}) at a concentration of 0.60 mg ml^-1^ (mean OD~595~ = 0.106).

10.1371/journal.pone.0207574.t008

###### Antimicrobial activity in mg ml^-1^ of *C*. *monspeliensis* methanol extract.

![](pone.0207574.t008){#pone.0207574.t008g}

  *C*. *monspeliensis*                                          
  -------------------------------------- ------ ------- ------- -------
  *Streptococcus mutans* DSM 20523       2.50   NA      10.00   NA
  *Streptococcus sobrinus* DSM 20381     2.50   5.00    20.00   20.00
  *Streptococcus oralis* ATCC 35037      0.15   0.60    10.00   20.00
  *Enterococcus faecalis* ATCC 29212     5.00   10.00   20.00   NA
  *Candida albicans* DSM 1386            5.00   10.00   5.00    NA
  *Escherichia coli* ATCC 25922          NA     NA      20.00   NA
  *Staphylococcus aureus* ATCC 25923     0.60   2.50    20.00   NA
  *Porphyromonas gingivalis* W381        0.04   0.15    20.00   20.00
  *Prevotella intermedia* MSP 34         0.08   0.08    2.50    5.00
  *Fusobacterium nucleatum* ATCC 25586   0.60   0.60    10.00   10.00
  *Parvimonas micra* ATCC 23195          0.04   0.08    10.00   20.00

NA: No activity observed, MIC or MBC of extracts and DMSO at 10.00 mg ml^-1^ and 20%, respectively.

MIC = extract concentration at which the OD measurement revealed minimal bacterial growth.

MBC = extract concentration at which a 3-Log reduction (99.9%) of the bacterial growth was induced.

*R*. *officinalis* and *S*. *sclarea* significantly reduced growth of all oral bacteria and biofilm growth of *S*. *mutans* {#sec015}
---------------------------------------------------------------------------------------------------------------------------

In general, the methanol extract of *R*. *officinalis* was extremely effective against all tested pathogens ([Table 9](#pone.0207574.t009){ref-type="table"}). The MIC values ranged from 0.08 mg ml^-1^ (*P*. *micra*) to 5.00 mg ml^-1^ (*E*. *faecalis*), with the highest efficacy among the streptococci on *S*. *oralis* at 0.30 mg ml^-1^. Similarly, the MBC values showed bactericidal effects in a range from 0.15 mg ml^-1^ (*P*. *micra*) to 5.00 mg ml^-1^ (*E*. *faecalis*). The extract had no significant effects on *C*. *albicans* and *E*. *coli*. The biofilm formation of *S*. *mutans* substantially decreased (mean OD~595~ = 0.038) at a *R*. *officinalis* concentration of 1.25 mg ml^-1^ ([Fig 4](#pone.0207574.g004){ref-type="fig"}).

10.1371/journal.pone.0207574.t009

###### Antimicrobial activity in mg ml^-1^ of *R*. *officinalis* methanol extract.

![](pone.0207574.t009){#pone.0207574.t009g}

  *R*. *officinalis*                                             
  -------------------------------------- ------- ------- ------- -------
  *Streptococcus mutans* DSM 20523       0.60    2.50    5.00    NA
  *Streptococcus sobrinus* DSM 20381     1.25    2.50    20.00   NA
  *Streptococcus oralis* ATCC 35037      0.30    0.60    20.00   20.00
  *Enterococcus faecalis* ATCC 29212     5.00    5.00    20.00   NA
  *Candida albicans* DSM 1386            10.00   10.00   10.00   NA
  *Escherichia coli* ATCC 25922          10.00   10.00   20.00   NA
  *Staphylococcus aureus* ATCC 25923     0.60    1.25    20.00   NA
  *Porphyromonas gingivalis* W381        0.15    0.30    20.00   20.00
  *Prevotella intermedia* MSP 34         0.30    0.60    5.00    5.00
  *Fusobacterium nucleatum* ATCC 25586   1.25    1.25    10.00   20.00
  *Parvimonas micra* ATCC 23195          0.08    0.15    5.00    20.00

NA: No activity observed, MIC or MBC of extracts and DMSO at 10.00 mg ml^-1^ and 20%, respectively.

MIC = extract concentration at which the OD measurement revealed minimal bacterial growth.

MBC = extract concentration at which a 3-Log reduction (99.9%) of the bacterial growth was induced.

The mean MIC and MBC values for the methanol extract of S. *sclarea* are presented in [Table 10](#pone.0207574.t010){ref-type="table"}. The MIC values vary between 0.08 mg ml^-1^ (*P*. *micra*) and 2.50 mg ml^-1^ (*S*. *sobrinus*). *S*. *sclarea* extract at 0.15 mg ml^-1^ induced a 3-Log reduction of *P*. *gingivalis* and *P*. *micra*, whereas a higher *S*. *sclarea* concentration at 5.00 mg ml^-1^ was needed to eradicate *S*. *mutans* and *S*. *sobrinus*. *E*. *coli*, *E*. *faecalis* and *C*. *albicans* were not affected by the extract. Significant inhibition of biofilm formation of *S*. *mutans* (mean OD~595~ = 0.088) by *S*. *sclarea* was shown at a concentration of 2.50 mg ml^-1^ ([Fig 4](#pone.0207574.g004){ref-type="fig"}).

10.1371/journal.pone.0207574.t010

###### Antimicrobial activity in mg ml^-1^ of *S*. *sclarea* methanol extract.

![](pone.0207574.t010){#pone.0207574.t010g}

  *S*. *sclarea*                                                 
  -------------------------------------- ------- ------- ------- -------
  *Streptococcus mutans* DSM 20523       1.25    5.00    5.00    NA
  *Streptococcus sobrinus* DSM 20381     2.50    5.00    20.00   NA
  *Streptococcus oralis* ATCC 35037      0.60    0.60    20.00   20.00
  *Enterococcus faecalis* ATCC 29212     10.00   10.00   20.00   NA
  *Candida albicans* DSM 1386            10.00   10.00   10.00   NA
  *Escherichia coli* ATCC 25922          10.00   10.00   20.00   NA
  *Staphylococcus aureus* ATCC 25923     1.25    1.25    20.00   NA
  *Porphyromonas gingivalis* W381        0.15    0.15    20.00   20.00
  *Prevotella intermedia* MSP 34         0.15    0.30    5.00    5.00
  *Fusobacterium nucleatum* ATCC 25586   0.60    0.60    10.00   20.00
  *Parvimonas micra* ATCC 23195          0.08    0.15    5.00    20.00

NA: No activity observed, MIC or MBC of extracts and DMSO at 10.00 mg ml^-1^ and 20%, respectively.

MIC = extract concentration at which the OD measurement revealed minimal bacterial growth.

MBC = extract concentration at which a 3-Log reduction (99.9%) of the bacterial growth was induced.

*O*. *vulgare* and *T*. *longicaulis* demonstrated significant bactericidal activity against obligate anaerobes but low antibiofilm activity against *S*. *mutans* {#sec016}
------------------------------------------------------------------------------------------------------------------------------------------------------------------

The methanol extract of *O*. *vulgare* eradicated the tested oral bacteria in a range of MBC values from 0.30 mg ml^-1^ (*P*. *micra*) to 5.00 mg ml^-1^ for *E*. *faecalis*, *S*. *mutans* and *S*. *sobrinus*, as shown in [Table 11](#pone.0207574.t011){ref-type="table"}. The extract had nearly no antimicrobial impact on *C*. *albicans*, *E*. *coli* and the obligate anaerobe *P*. *intermedia*. The most significant inhibitory effect was induced at a *O*. *vulgare* concentration of 0.30 mg ml^-1^ on *P*. *gingivalis* and *P*. *micra* and at 0.60 mg ml^-1^ on *S*. *oralis*, respectively. Biofilm formation of *S*. *mutans* was significantly reduced (mean OD~595~ = 0.081) at 5.00 mg ml^-1^ *O*. *vulgare* extract, whereas lower extract concentration had no impact on *S*. *mutans* biofilms ([Fig 4](#pone.0207574.g004){ref-type="fig"}).

10.1371/journal.pone.0207574.t011

###### Antimicrobial activity in mg ml^-1^ of *O*. *vulgare* methanol extract.

![](pone.0207574.t011){#pone.0207574.t011g}

  *O*. *vulgare*                                                 
  -------------------------------------- ------- ------- ------- -------
  *Streptococcus mutans* DSM 20523       2.50    5.00    5.00    NA
  *Streptococcus sobrinus* DSM 20381     2.50    5.00    20.00   NA
  *Streptococcus oralis* ATCC 35037      0.60    1.25    10.00   20.00
  *Enterococcus faecalis* ATCC 29212     5.00    5.00    20.00   NA
  *Candida albicans* DSM 1386            10.00   10.00   10.00   10.00
  *Escherichia coli* ATCC 25922          10.00   10.00   20.00   NA
  *Staphylococcus aureus* ATCC 25923     1.25    1.25    20.00   NA
  *Porphyromonas gingivalis* W381        0.30    0.60    20.00   20.00
  *Prevotella intermedia* MSP 34         2.50    2.50    5.00    5.00
  *Fusobacterium nucleatum* ATCC 25586   1.25    1.25    10.00   10.00
  *Parvimonas micra* ATCC 23195          0.30    0.30    10.00   20.00

NA: No activity observed, MIC or MBC of extracts and DMSO at 10.00 mg ml^-1^ and 20%, respectively.

MIC = extract concentration at which the OD measurement revealed minimal bacterial growth.

MBC = extract concentration at which a 3-Log reduction (99.9%) of the bacterial growth was induced.

The antimicrobial activity of *T*. *longicaulis* on the tested bacterial strains and *C*. *albicans* is displayed in [Table 12](#pone.0207574.t012){ref-type="table"}. The MIC values varied from 0.08 mg ml^-1^ (*P*. *micra*) to 2.50 mg ml^-1^ (*S*. *sobrinus*, *E*. *coli*). The MBC values demonstrated the persistence of *C*. *albicans* and *E*. *coli* in the presence of 10.00 mg ml^-1^ *T*. *longicaulis* methanol extract, whereas all other strains were killed from 0.15 mg ml^-1^ (*P*. *micra*) to 2.50 mg ml^-1^ (*S*. *sobrinus*, *E*. *faecalis*). *T*. *longicaulis* inhibited strongly biofilm formation by *S*. *mutans* at 5.00 mg ml^-1^ (mean OD~595~ = 0.013) but also no statistically significant difference to CHX was detected at 2.50 mg ml^-1^ ([Fig 4](#pone.0207574.g004){ref-type="fig"}).

10.1371/journal.pone.0207574.t012

###### Antimicrobial activity in mg ml^-1^ of *T*. *longicaulis* methanol extract.

![](pone.0207574.t012){#pone.0207574.t012g}

  *T*. *longicaulis*                                            
  -------------------------------------- ------ ------- ------- -------
  *Streptococcus mutans* DSM 20523       0.60   1.25    5.00    NA
  *Streptococcus sobrinus* DSM 20381     2.50   2.50    10.00   NA
  *Streptococcus oralis* ATCC 35037      0.60   1.25    20.00   20.00
  *Enterococcus faecalis* ATCC 29212     1.25   2.50    20.00   NA
  *Candida albicans* DSM 1386            5.00   10.00   10.00   NA
  *Escherichia coli* ATCC 25922          2.50   10.00   20.00   NA
  *Staphylococcus aureus* ATCC 25923     0.60   0.60    20.00   NA
  *Porphyromonas gingivalis* W381        0.15   0.30    20.00   20.00
  *Prevotella intermedia* MSP 34         0.30   0.60    2.50    2.50
  *Fusobacterium nucleatum* ATCC 25586   0.60   0.60    5.00    10.00
  *Parvimonas micra* ATCC 23195          0.08   0.15    5.00    10.00

NA: No activity observed, MIC or MBC of extracts and DMSO at 10.00 mg ml^-1^ and 20%, respectively.

MIC = extract concentration at which the OD measurement revealed minimal bacterial growth.

MBC = extract concentration at which a 3-Log reduction (99.9%) of the bacterial growth was induced.

Discussion {#sec017}
==========

In this report all tested extracts effectively inhibited mainly the anaerobic oral microorganisms and in concentrations ≥0.3 mg ml^-1^ had moderate to high antibiofilm activity against *S*. *mutans* comparable to that of CHX. Lamiaceae is a family of great diversity and variety, containing important medicinal herbs with diverse biological properties. Most of the plants are aromatic and possess essential oils; however, they also contain important phenolic compounds. Additionally, *Cistus* species are widely spread in Europe and some, such as *C*. *monspeliensis* and *C*. *creticus* are typical components of the Mediterranean flora. Preliminary phytochemical analysis was performed with HPTLC, which is most recent evolution of planar chromatography, specifically tailored for the analysis of natural products. The microtiter plate test is an accepted standard biofilm assay, which has been used frequently in literature due to its practicability. It has the advantages to allow testing of different bacterial species or substances.

To date, most of the studies found in literature \[[@pone.0207574.ref043]--[@pone.0207574.ref045]\] have mainly reported on the antimicrobial effects of essential oils from *C*. *creticus*, *C*. *monspeliensis*, *O*. *vulgare*, *R*. *officinalis*, *S*. *sclarea* and *T*. *longicaulis* on "non-oral" bacterial pathogens and *C*. *albicans*. To the best of our knowledge, this is the first report on the antibacterial and antibiofilm effectiveness of methanol extracts from the aforementioned herbs against various oral pathogens.

In the present report, *C*. *creticus* and *C*. *monspeliensis* extracts inhibited effectively obligate anaerobes such as *P*. *gingivalis*, *P*. *micra* and *P*. *intermedia*. To date, several studies \[[@pone.0207574.ref043], [@pone.0207574.ref045]--[@pone.0207574.ref048]\] have confirmed the enhanced antimicrobial activity of *Cistus* spp. against diverse "non-oral" bacteria and fungi. Interestingly, six out of seven labdane-type isolated diterpenes from leaves of *C*. *creticus* L. showed inhibitory effects against the Gram-negative *Pseudomonas aeruginosa* and *Klebsiella pneumoniae* \[[@pone.0207574.ref043]\]. As the methanol extract of *C*. *creticus* exhibited no significant antimicrobial activity against *E*. *coli* in this study, the resulted MIC value was comparable with the relative high MIC ≥3 mg ml^-1^ of a hexane leaf extract of *C*. *creticus* L. \[[@pone.0207574.ref047]\]. In another report, Bouamama *et al*. \[[@pone.0207574.ref045]\] tested *C*. *monspeliensis* methanol extract against *E*. *coli* and exhibited no activity of the extract accounting for a MIC of 25 mg ml^-1^.

In general, facultative anaerobic Gram-negative bacteria are more resistant to the *Cistus* spp. extracts than Gram-positive microorganisms \[[@pone.0207574.ref048]\], while obligate anaerobes are more sensitive to *Cistus* spp. treatment. This is due to the fact that the outer bacterial cell membrane of Gram-negative bacteria serves as a dense permeability barrier that hinders the penetration of lipophilic molecules \[[@pone.0207574.ref049], [@pone.0207574.ref050]\]. The Gram-positive bacteria with thicker cell walls than the Gram-negative bacteria also develop defense strategies against antimicrobials such as the production of extracellular proteases and the chemical modification of cell membrane or cell wall \[[@pone.0207574.ref051], [@pone.0207574.ref052]\]. In an earlier *in situ* report \[[@pone.0207574.ref053]\], rinsing of the oral cavity with Cistus tea resulted in the reduction of adherent bacteria on enamel surfaces. In the present report, the high antibacterial activity of the *Cistus* spp. extracts against the Gram-positive *S*. *oralis* and *S*. *aureus* contradicted the significantly lower susceptibility of *S*. *aureus* to *C*. *monspeliensis* methanol extract (MIC = 25 mg ml^-1^) demonstrated by Bouamama *et al*. \[[@pone.0207574.ref045]\]. Nevertheless, the hexane leaf extract of *C*. *creticus* showed high bacterial growth inhibition of *S*. *aureus* and *E*. *faecalis* (MIC = 0.5 mg ml^-1^) in an earlier report by Anastasaki *et al*. \[[@pone.0207574.ref047]\]. The conflicting outcomes can be ascribed to the differing extraction methods used. In regard with the antifungal activity, even after the application of high-concentrated extracts, *C*. *albicans* could not be effectively killed \[[@pone.0207574.ref043], [@pone.0207574.ref045]--[@pone.0207574.ref047]\].

The tested rosemary and sage extracts significantly reduced the growth of all screened oral bacteria such as streptococci and *E*. *faecalis*. Although the methanol extract of *R*. *officinalis* reduced *S*. *mutans* (MIC = 0.60 mg ml^-1^) effectively in this report, the inhibition level of *S*. *sobrinus* and *F*. *nucleatum* (MIC = 1.25 mg ml^-1^) was moderate. Surprisingly, the phenols carnosic acid and carnosol enabled the activity of various conventional antibiotics against overexpressing efflux pumps in *S*. *aureus* strains \[[@pone.0207574.ref054]\]. In contrast, an rosemary EO tested by Hammer *et al*. \[[@pone.0207574.ref055]\] failed to inhibit *E*. *faecalis* at 2% (v/v).

In a randomized double-blind placebo-controlled trial a polyherbal mouthwash rinsing containing *R*. *officinalis* among three hydroalcoholic extracts, showed a high antibacterial efficacy comparable to 0.2% (w/v) CHX in the treatment of gingivitis \[[@pone.0207574.ref056]\]. Since new rosemary compounds have been isolated lately \[[@pone.0207574.ref057]\], further antimicrobial screening of rosemary is required.

The positive antimicrobial effects of *S*. *sclarea* methanol extract are in agreement with the MIC values against *S*. *aureus* and *E*. *coli* revealed by Firuzi *et al*. \[[@pone.0207574.ref058]\], but do not correspond to the low antibacterial activity against *S*. *aureus* shown by Stagos *et al*. \[[@pone.0207574.ref059]\]. The results are in accordance to the low susceptibility shown by Hammer *et al*. \[[@pone.0207574.ref055]\]. In the present study, the high antibacterial activity against facultative anaerobic oral pathogens was confirmed \[[@pone.0207574.ref060]\]. Finally, the main *S*. *sclarea* components, the diterpenoids salvipisone and aethiopinone, revealed both bactericidal and antibiofilm activity against *S*. *aureus* and *S*. *epidermidis* strains \[[@pone.0207574.ref061], [@pone.0207574.ref062]\].

Although the *O*. *vulgare* methanol extract effectively killed Gram-negative obligate anaerobes in this study, *S*. *aureus* and *E*. *coli* were not as susceptible to extract treatment contrary to the outcomes of previous reports on an ethanol extract \[[@pone.0207574.ref063]\] and an EO \[[@pone.0207574.ref055]\]. The discrepancies can be attributed to different extraction solvents used, MIC method or different chemical composition of the extract used.

In the present report, *T*. *longicaulis* eradicated both Gram-positive and Gram-negative bacteria confirming the results of earlier studies, in which higher amounts of carvacrol accounted for higher antibacterial efficacy than geraniol \[[@pone.0207574.ref064], [@pone.0207574.ref065]\]. The similar inhibitory concentrations of *T*. *longicaulis* EO as presented by De Martino *et al*. \[[@pone.0207574.ref066]\] disprove the importance of the ratio between oxygenated monoterpenes and monoterpene hydrocarbons. This implies that, beside the fact of using different classification for phenols, the variety of synergistic and additional modes of antimicrobial action can be related to both inactive and weakly active compounds in different quantitative proportions.

There is a limited amount of reports on the antibiofilm activity of the tested plant species \[[@pone.0207574.ref061], [@pone.0207574.ref062], [@pone.0207574.ref067], [@pone.0207574.ref068]\]. Two main components of *S*. *sclarea*, namely salvipisone and aethiopinone, effectively reduced biofilm volume produced by *S*. *aureus* and *S*. *epidermidis* \[[@pone.0207574.ref061], [@pone.0207574.ref062]\]. Since intraoral bacterial glucosyltransferases (GTases) synthesize main extracellular matrix substrates such as glucan and fructan from sucrose contributing to the bacterial biofilm formation on tooth surfaces, the enhanced inhibitory activity of aqueous and methanol extract of rosemary against GTase of *S*. *sobrinus* is noteworthy \[[@pone.0207574.ref067]\]. This was confirmed by Quave *et al*. \[[@pone.0207574.ref068]\] with an ethanol extract, which reduced biofilm production of methicillin-resistant *S*. *aureus*. Even *P*. *aeruginosa* was eradicated by the EO of *O*. *vulgare* spp. Interestingly, in the present study although the OD values of the extracts were generally more scattered compared to the OD values of CHX, extract concentrations ≥0.3 mg ml^-1^ had moderate to high antibiofilm activity against *S*. *mutans*.

In conclusion, all tested Mediterranean herbs inhibited effectively the screened obligate anaerobic oral microorganisms. Thus, the null hypothesis was rejected. The outcome of this microbiological screening encourages further investigations to encounter and develop natural components with antimicrobial and antibiofilm activity against oral pathogens. Due to the increasing incidence of multi-resistant bacteria despite the use of oral disinfectants e.g. chlorhexidine, the application of herb extracts could prove to be an effective alternative treatment strategy against oral pathogens \[[@pone.0207574.ref069], [@pone.0207574.ref070]\]. Interestingly, diverse side effects of conventional oral care products such as allergies, intolerable taste, tooth coloring, toxicity, and antimicrobial resistance have triggered the search for alternative, in best case natural, antimicrobials. The development of natural resources is crucial for developing countries contributing to economic growth and enhancing people's health at low cost \[[@pone.0207574.ref022], [@pone.0207574.ref060], [@pone.0207574.ref071], [@pone.0207574.ref072]\]. Overall, methanol extracts from *R*. *officinalis* and *S*. *sclarea* had the most significant antimicrobial effects against all tested oral pathogens, while *Cistus* spp. extracts exhibited the highest antibiofilm activity against *S*. *mutans*. Thus, combinations of these plant extracts could serve as main antimicrobial components in alternative antibacterial formulations facilitating the prevention of biofilm-related oral diseases such as caries or periodontitis.
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CBA

:   Columbia blood agar plates

CFU

:   colony forming units

CHX

:   chlorhexidine

CLSI

:   Clinical and Laboratory Standards Institute

DSM

:   German Collection of Microorganisms and Cell Cultures

EO

:   essential oil

GTase

:   glucosyltransferase

HCB

:   yeast-cysteine blood agar plates

MBC

:   minimal bactericidal concentration

MHB

:   BBL Mueller Hinton II Broth-Cation-Adjusted

MHB-S

:   MHB containing 1% saccharose

MIC

:   minimal inhibitory concentration

OD

:   optical density

PBP

:   penicillin binding protein

QS

:   quorum sensing

UAE

:   ultrasound assisted extraction

WCB

:   Wilkins-Chalgren broth
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